Cardiology calls for papers / meetings & conferences

Call for Papers: 1st Annual International Conference on Cardiology & Cardiovascular Medicine Research (CCMR 2013)

December 9-10, 2013 Singapore

Full Paper Submission Deadline: 2nd August 2013 

The Annual International Conference on Cardiology & Cardiovascular Medicine Research (CCMR) aims to be a platform for researchers, cardiologists, cardiac surgeons, and educators all over the world to present, share and exchange new medicine studies, research results, research analysis, innovations and advances in dealing with heart disorders or cardiovascular disease. The theme tends to be broad to incorporate the overarching perspective within the field of Cardiology and Cardiovascular Medicine.

Papers/topics dealing with Advances in Cardiology & Cardiovascular Medicine Research including but not limited to:

• Acute Coronary Syndromes (ACS)

• Arrhythmias

• Atrial Fibrillation

• Cardiac Emergencies

• Cardiac Surgeries

• Cardiomyopathy

• Congenital Heart Disease

• Diagnostic Imaging and Biomarkers

• Genomic Medicine

• Heart & Lung Transplant

• Heart Failure

• Hypertension

• Interventional Cardiology

• Lipids and Cardiovascular Risk Management

• Medical Devices in Cardiology

• Vascular Disease

• Vascular Surgery

• Cardiology

• Cardiovascular Medical Research

• Preventive Cardiology

• Diseases of the Aorta

• Cardiac Tumors

• Cardiac rehabilitation

• Community Cardiology

• Resuscitation

• Disorders of the coronary circulation

• Cardiac Arrest

• Disorders of the myocardium (muscle of the heart)

• Disorders of the pericardium (outer lining of the heart)

• Disorders of the heart valves

• Congenital heart defect

• Diseases of blood vessels (vascular diseases)

• Devices used in cardiology

• Diagnostic tests and procedures

CCMR CONFERENCE SECRETARIAT
Global Science & Technology Forum (GSTF)
10 Anson Road, International Plaza,
Singapore 079903
DID : +65 6327 0166
Fax : +65 6327 0162

For General Enquiries info@cardioresearch-conf.org

Call for Abstracts: Innovations in Cardiovascular Interventions (ICI Meeting 2013)

“Innovations in Cardiovascular Interventions (ICI) - From Idea to Reality" will be held on December 1-3, 2013 in Tel-Aviv, Israel

The Deadline for Abstract Submission is July 10, 2013.

The upcoming meeting will focus on innovative technology and therapies in the cardiovascular area and related exciting disciplines and will cover all stages of the innovation process from the bench to the patient bedside.

This year we will continue to watch closely the dynamic and vibrant area of valvular interventions and the many innovations under investigation for treating cardiac valvular pathology using percutaneous techniques or combined surgical and interventional pathways.

This year we will continue to review the regulatory, ethical and financial aspects of new devices and continue the Mobile health track that was an exciting topic last year which will continue with a special flavour within the scientific program.

Who should attend: Clinical cardiologists, innovative scientists, biomedical engineers, financial investors seeking opportunities and members of cutting edge teams in major companies in this field, who want to be part of the future of interventional cardiology.

All the posters this year will be presented as E-posters. Poster submitters do not need to bring a printed copy of their poster

Confirmations will be sent by July 21, 2013.

Submitters that their abstract has been accepted will have to register no later than October 6, 2013.

What is an E-poster?

• The E-poster is a poster presented as a PDF presentation.

• The E-poster presentations will be presented on a computer screen during the congress and not on  a regular poster board.

• Few computer stands will be distributed among the congress exhibition area.

• The E-poster system allows every delegate to see all e-poster presentations.

• The E-poster system allows you to search presentations by: Authors name, Abstract Title and Topic.

• The E-poster system allows you to save a presentation on site either on disk-on key or send it by e- mail.

• The uploaded E-poster should contain the same title, order of authors and affiliation details as the submitted abstract.

Contact Us

ICI Secretariat:
Dan Knassim Ltd.
60 Medinat Hayehudim st.
P.O.Box 4195
Herzliya 46766
Israel
Tel/fax: 972-3- 5767739
Email: secretariat@icimeeting.com

Call for Late Breaking Clinical Trials and First Report Investigations: TCT 25

October 27-November 1, 2013 San Francisco, California

Submission Deadline: August 20, 2013

Late breaking clinical trials are typically first-time international or US presentations of the primary endpoint or important secondary endpoint results of prospective, randomized clinical trials or presentations of large-scale, impactful single-center or multicenter registries, first-in-man experiences with novel devices or drugs, and important follow-up data from major randomized trials.

A late breaking clinical trial is defined as a major randomized trial or large-scale observational study. A first report investigation is a smaller randomized trial, novel science, or early human investigation.

Accepted late breaking clinical trial and first report investigation submissions will be presented in the Main Arena at TCT 2013, and accepted late breaking clinical trials will also be presented at press conferences scheduled on the same days as the presentations.

Call for Challenging Cases: TCT 25

October 27-November 1, 2013 San Francisco, California

Submission Deadline: July 31, 2013

New and Emerging Technology Demonstrations

The directors of TCT are requesting interesting cases demonstrating new and emerging technologies in use in humans, as part of the call for challenging cases. Physicians from around the world are invited to submit their most challenging coronary intervention, endovascular intervention, and structural heart disease cases, and the directors of TCT will review each submitted case.

A subset of cases will be considered provisionally accepted for publication in Catheterization and Cardiovascular Interventions, and fellows and early practitioners with accepted submissions will have their registration fees waived.
 

Call for Investigational and Emerging Technologies Edited Live Case Presentations: TCT 25

October 27-November 1, 2013 San Francisco, California

Submission Deadline: July 26, 2013

A presentation opportunity at TCT 2013, you can submit your own edited taped case demonstrating a novel therapeutic or imaging technology in coronary, peripheral, or structural heart disease intervention that provides a unique solution for an unmet clinical need. The technology can be either investigational or in clinical use outside of the United States but not yet commercially available in the United States.

Case submitters will have the opportunity to present the edited taped case during TCT Week to a world-renowned panel of key opinion leaders, and those with accepted submissions will become TCT faculty and have their registration fees waived. Excellent examples include new percutaneous valves, heart failure support devices, novel peripheral atherectomy system, cerebral thrombus extraction device, large hole vascular closure, etc.

Description of an Edited Live Case

An edited live case is a case demonstration that typically consists of capturing the following elements of an interventional procedure performed in a cath lab in real time:

• Narrated patient history slides and an introduction of the case

• A wide camera shot of the primary operator from across the table narrating the demonstration

• A close up camera shot of devices and techniques from the foot of the table

• Live imaging captured from fluoroscopy, echo, IVUS, etc

These sources are then edited together with the operator's audio narration to show a point of interest at each phase of the case. Often picture-in-picture (PIP) technology is used to allow for multiple images to appear on screen concurrently. Periods of inactivity are removed to reduce the overall playtime of the case.

Please view a sample of an edited case: www.crf.org/jchamlee/i2_cases.html

Submission Guidelines

Step 1: Case Summary

• A written summary no more than 500 words describing your case. This is submitted online

• The deadline to submit your summary is July 26, 2013

After receiving notification of your accepted summary, you will be asked to complete step 2 (below).

Step 2: Edited Live Case

• Insert two (2) to three (3) introductory slides describing the technology at the beginning of the edited taped case

• The edited case must be submitted by express mail on a playable DVD, NTSC 4:3 format and can be no longer than 15 minutes

• The case should be edited so there are clear and concise teaching points. There should also be places in the presentation where the case can be paused to allow for panel discussion.

• The presentation is strictly for educational purpose and is not promotional although the company manufacturing the device may be acknowledged once at the beginning of the presentation

• No company logos are allowed

• All patient identifying information must be removed throughout the presentation in accordance with HIPAA guidelines

Final cases will be reviewed for acceptance. Accepted cases will be reviewed and additional edits may be suggested as necessary.

If you have questions about the suitability of a device, please contact Margaret Zetts at mzetts@crf.org.

Call for Abstracts: TCT 25

October 27-November 1, 2013 San Francisco, California

Submission Deadline: June 12, 2013

Abstract submissions should address an area of interventional cardiology, endovascular medicine, or structural heart disease (clinical studies, basic science investigation, and preclinical studies are equally encouraged) and constitute original research but may include portions of prior abstracts and/or manuscripts presented elsewhere.

Accepted abstracts will be published in the Journal of the American College of Cardiology (JACC) TCT Abstract Supplement, and fellows and early practitioners will have their registration fees waived.

If you have any questions, please e-mail abstracts@crf.org.

Call for Abstracts: 5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus

21-24 November, 2013 Bangkok, Thailand

Deadline for Submission of Abstracts: 18 June 2013

Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.

Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often  necessary to reach  early and sustained achievement of individualized  glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.

The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.

List of Topics

•  Treatment Simplification and Compliance

•  FDCs as First Step Treatment

•  FDC in Secondary Prevention

•  FDCs of Antihypertensive and Antidiabetic Drugs

•  FDCs of Antihypertensive and Lipid Lowering Drugs

•  FDC in the Elderly and Very Elderly

•  Ambulatory BP in the Assessment of FDC Efficacy

•  Home BP in the Assessment of FDC Efficacy

•  Combinations with Thiazides. Chlortalidone vs HCTZ

•  ACE Inhibitors  and  Diuretics FDC

•  ACE Inhibitors  and  Calcium Channel Blockers FDC

•  ARBs  and Diuretics  FDC

•  ARBs  and Calcium Channel Blockers  FDC

•  Triple Drug Combinations

•  The Polypills

•  FDCs as Generic Drugs

•  Guidelines

•  FDCs in Different Countries

•  Regulatory Aspects

•  Cost Issues

Contact Us

Conference Organizers

Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel:  +41 (0)22 533 0948     
Fax: +41 (0)22 580 2953

General Enquiries
Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com   
Fax: +41 (0)22 580 2953

Call for Abstracts: Third International Congress on Cardiac Problems in Pregnancy

February 20-23, 2014 Venice, Italy

The deadline for abstract submission is September 16, 2013.

The goals of “The Third International Congress on Cardiac Problems in Pregnancy” are to continue advancing the knowledge and expertise of health care professionals around the globe by exchange of information, development of collaborative research both basic and clinical, discuss, adopt and upgrade recent guidelines for the management of cardiovascular conditions during pregnancy and the post partal period. The program will include invited lectures, workshops as well as original oral and poster presentations which will cover a wide spectrum of topics in all disciplines related to pregnancy associated cardiovascular conditions.

Who Should Attend?

This Congress is intended for:

Cardiologists

Gynecologists

Obstetricians

Anesthesiologists

Internists

Hypertension specialists

Medical Imaging Technicians